Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Crohn’s Disease (CD) Treatment Market Covering 2025–2034?
The crohn’s disease (cd) treatment market size has demonstrated consistent growth in recent years. It is projected to increase from $11.76 billion in 2024 to $12.32 billion in 2025, at a compound annual growth rate (CAGR) of 4.8%. Historically, this expansion has been driven by the rising prevalence of crohn’s disease, growing awareness of the illness, government initiatives, and changing lifestyles.
The crohn’s disease (cd) treatment market is projected to experience robust expansion over the coming years. By 2029, this market is anticipated to reach a valuation of $15.01 billion, demonstrating a compound annual growth rate (CAGR) of 5.1%. This anticipated growth during the forecast period is primarily driven by factors such as the rising demand for combination therapies, the increasing use of biologics, and continued investments in research and development concerning crohn’s disease (cd) treatments. Key trends expected within this period encompass the advancement of biologic drugs, the introduction of innovative products, the availability of advanced diagnostic tools, and the wider adoption of biosimilars.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12902&type=smp
What Are The Top Growth Drivers Impacting The Crohn’s Disease (CD) Treatment Market Outlook?
The rising occurrence of inflammatory bowel diseases is anticipated to significantly boost the expansion of the Crohn’s disease (CD) treatment market in the foreseeable future. Inflammatory bowel disease (IBD) refers to a collection of chronic inflammatory conditions that primarily affect the gastrointestinal (GI) tract. Treatments for Crohn’s disease (CD) are designed to alleviate symptoms, reduce inflammation, encourage remission, and improve the overall quality of life for individuals living with this chronic inflammatory bowel condition. As an illustration, the United States National Library of Medicine, a US-based medical library, reported in September 2023 that in Canada, the incidence of inflammatory bowel diseases (IBD) was estimated at 30 per 100,000 person years in 2023, with projections indicating a steady increase of approximately 0.58% annually. Furthermore, by 2023, the prevalence of IBD in Canada reached around 825 per 100,000, with forecasts suggesting this could climb to 1.1% of the population by 2035. Therefore, the expanding prevalence of inflammatory bowel diseases is a key driver for the Crohn’s disease (CD) treatment market.
What Are The Major Segment Categories Driving The Crohn’s Disease (CD) Treatment Market Growth?
The crohn’s disease (cd) treatmentmarket covered in this report is segmented –
1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
2) By Route of Administration: Oral; Injectable
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores
Subsegments:
1) By Antibiotics: Metronidazole; Ciprofloxacin; Rifaximin
2) By Amino Salicylates: Mesalamine; Sulfasalazine
3) By Corticosteroids: Prednisone; Budesonide; Hydrocortisone
4) By Immunomodulators: Azathioprine; Mercaptopurine; Methotrexate
5) By Other Drug Types: Biologic Therapies; Janus Kinase Inhibitors; Small Molecules
How Are Trends Influencing The Crohn’s Disease (CD) Treatment Market?
Leading companies within the Crohn’s disease (CD) treatment market are deploying new technologies, such as IBDSENSE, to secure their market standing. For example, in March 2023, The IRR Chemistry Hub, an interdisciplinary hub situated in Scotland, developed IBDSENSE. This technology is designed to enhance the diagnosis and monitoring of inflammatory bowel disease, including Crohn’s disease, through non-invasive approaches. The project utilizes fluorescence-based technology to assess the enzyme activity of Granzyme B (GzmB) in patient biosamples. This innovation aims to improve patient experience and diversify treatment options.
Who Are The Primary Competitors In The Global Crohn’s Disease (CD) Treatment Market?
Major companies operating in the crohn’s disease (cd) treatment market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
Which Geographies Are Emerging As Strong Markets For The Crohn’s Disease (CD) Treatment Industry?
North America was the largest region in the Crohn’s disease (CD) treatment market in 2024. The regions covered in Crohn’s disease (CD) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Crohn’s Disease (CD) Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12902&type=smp
Browse Through More Reports Similar to the Global Crohn’s Disease (CD) Treatment Market 2025, By The Business Research Company
Inflammatory Bowel Disease Treatment Global Market Report 2025
Irritable Bowel Syndrome Ibs Treatment Global Market Report 2025
Gastric Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model